Abstract:Bisphenol A (BPA) is a known endocrine disruptor mimicking natural estrogens with the potential to affect human health, especially during prenatal and postnatal exposure at or below current acceptable daily intake levels. Different adverse effects of BPA are still under investigation, and multiple mechanisms of action remain unexplored. This may be one of the reasons for the continuously changing tolerable daily intake (TDI) of BPA with the emergence of new adverse health effects over time. In addition, translational modelling through in vitro-in vivo extrapolation (IVIVE) can act as prerequisite bridge for translating in-vitro finding into human risk assessment. The objective of this study was to conduct in-vitro experiments and utilize an IVIVE-pregnancy physiologically based pharmacokinetic (P-PBPK) modeling to investigate developmental neurotoxicity and embryotoxicity in humans. The data obtained from human embryonic stem cells-based assays (study conducted between October 2020-2021) were used for the IVIVE-P-PBPK models to obtain the human equivalent doses (HEDs) which were further extrapolated to reference doses (RfDs). The results showed that simulated mean RfDs (μg/kg/day) derived from the HSD3B1 and NFATC2 gene of embryotoxicity and neurodevelopmental toxicity tests, respectively, were 4.94 and 5.18. The simulated RfDs were close to the temporary-tolerable daily intake (t-TDI) recommended by European Food Safety Authority (EFSA) in 2015 (t-TDI: 4 μg/kg·bw) and higher than the TDI of 2023 (0.2 ng/kg·bw). In conclusion, in-vitro toxicogenomics dose-response data combined with PBPK modeling can become a promising alternative new approach methodology (NAM) to support decision-making in chemical risk assessment. Based on the simulated RfDs derived from this NAM, the t-TDI set by EFSA in 2015 may be considered a safe exposure limit for mothers and fetuses at the current BPA intake levels in Chinese mothers. This study provided an animal-free new strategy for NAMs based risk assessment by combining toxicogenomics and computational toxicology.

Animal-free assessment of developmental toxicity: Combining PBPK modeling with the ReproTracker assay

Optimization of the TeraTox assay for preclinical teratogenicity assessment

Analyzing high-throughput assay data to advance the rapid screening of environmental chemicals for human reproductive toxicity

Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach

PregPred: an In-Silico Alternative to Animal Testing for Predicting Developmental Toxicity Potential

Discovery Phase Agrochemical Predictive Safety Assessment Using High Content In Vitro Data to Estimate an In Vivo Toxicity Point of Departure

IVIVE-PBPK based new approach methodology for addressing early life toxicity induced by Bisphenol A

New approach methodologies to confirm developmental toxicity of pharmaceuticals based on weight of evidence

Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing

The DevTox Germ Layer Reporter Platform: An Assay Adaptation of the Human Pluripotent Stem Cell Test

Applications of Zebrafish Embryo Models to Predict Developmental Toxicity for Agrochemical Product Development

An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds

Human Pluripotent Stem Cell-Based Assays to Predict Developmental Toxicity

Screening and characterization of 133 physiologically-relevant environmental chemicals for reproductive toxicity

Mechanistic screening of reproductive toxicity in a novel 3D testicular co-culture model shows significant impairments following exposure to low-dibutyl phthalate concentrations

Rapid quantitative high-throughput mouse embryoid body model for embryotoxicity assessment

Multi-cellular engineered living systems to assess reproductive toxicology

The Human Induced Pluripotent Stem Cell Test as an Alternative Method for Embryotoxicity Testing

Engineering a Computable Epiblast for in silico Modeling of Developmental Toxicity

An Integrated Microfluidic Array System for Evaluating Toxicity and Teratogenicity of Drugs on Embryonic Zebrafish Developmental Dynamics

In vitro teratogenicity testing using a 3D, embryo-like gastruloid system